Literature DB >> 7026410

Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections.

F K Conley, K A Jenkins, J S Remington.   

Abstract

The peroxidase-antiperoxidase immunohistochemical technique was employed to stain formalin fixed, paraffin embedded tissue sections from three cases of encephalitis caused by Toxoplasma gondii. We studied two cases of congenital infection and one case of acquired toxoplasmosis occurring in an immunocompromised host. The peroxidase-antiperoxidase method was exquisitely sensitive and highly specific and stained both the encysted and tachyzoite forms of the organism, as well as allowing for easy identification of infected cells. In two cases of necrotizing encephalitis--one congenital, the other acquired--widespread dissemination of the Toxoplasma organism throughout the neural parenchyma was visualized using the peroxidase-antiperoxidase stain. Brain biopsy material that had been obtained eight days prior to death in the case of adult acquired toxoplasmosis did not contain any of the characteristic tissue cysts and was not diagnostic for toxoplasmosis by conventional staining techniques. However, peroxidase-antiperoxidase staining of tissue sections from this biopsy unequivocally demonstrated both free tachyzoites and multiple infected cells. Further application of the peroxidase-antiperoxidase method should increase our understanding of the pathology and pathogenesis of toxoplasmic encephalitis as well as allowing timely diagnosis in cases presenting with neurologic symptomatology.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026410     DOI: 10.1016/s0046-8177(81)80170-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  37 in total

1.  Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.

Authors:  N Schöler; K Krause; O Kayser; R H Müller; K Borner; H Hahn; O Liesenfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases.

Authors:  C Strittmatter; W Lang; O D Wiestler; P Kleihues
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Brain-tissue cysts in rats infected with the RH strain of Toxoplasma gondii.

Authors:  V Lecomte; B F Chumpitazi; B Pasquier; P Ambroise-Thomas; F Santoro
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

4.  Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.

Authors:  Y Suzuki; M A Orellana; S Y Wong; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

5.  The diagnosis of toxoplasmosis.

Authors:  G N Dutton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

6.  A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; K Joh; M A Orellana; F K Conley; J S Remington
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

7.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

8.  Diagnosis of Toxoplasma gondii infection in AIDS patients by a tissue-culture technique.

Authors:  C Contini; R Romani; S Magno; S Delia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

9.  Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

Authors:  Xisheng Wang; Hoil Kang; Takane Kikuchi; Yasuhiro Suzuki
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Toxoplasmosis during pregnancy: a case report and review of the literature.

Authors:  C Giannoulis; B Zournatzi; A Giomisi; E Diza; I Tzafettas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.